Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition

Annals of Oncology

Volumn 26, Issue 11, 2015, Pages 2335-2340

  Bozzetti, F ^a   Cotogni, P ^b   Lo Vullo, S ^c   Pironi, L ^d   Giardiello, D ^c   Mariani, Luigi ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cancer cachexia; home parenteral nutrition; incurable cancer patient; malignant obstruction; nomogram; survival prediction

Indexed keywords

ADULT; ARTICLE; BODY MASS; CACHEXIA; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLASGOW PROGNOSTIC SCORE; HOME CARE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NOMOGRAM; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR LOCALIZATION; VALIDATION PROCESS; WEIGHT REDUCTION; ADOLESCENT; AGED; CLINICAL TRIAL; FOLLOW UP; MORTALITY; MULTICENTER STUDY; NEOPLASMS; PREDICTIVE VALUE; TRENDS; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CACHEXIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NOMOGRAMS; PARENTERAL NUTRITION, HOME; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; YOUNG ADULT;

EID: 84947813786     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv365     Document Type: Article

References (22)

1. Bozzetti F, Arends J, Lundholm K et al. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 2009; 28: 445-454.
2. August DA, Huhmann MB; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 2009; 33: 472-500.
3. Bozzetti F, Santarpia L, Pironi L et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 2014; 25: 487-493.
4. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. Cancer 2005; 103: 863-868.
5. Fan BG. Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. JPEN J Parenter Enteral Nutr 2007; 31: 508-510.
6. Soo I, Gramlich L. Use of parenteral nutrition in patients with advanced cancer. Appl Physiol Nutr Metab 2008; 33: 102-106.
7. Brozek J, Well S, Keys A. Medical aspects of semistarvation in Leningrad (siege 1941-1942). Am Rev Sov Med 1946; 4: 70-86.
8. Fliederbaum J. Clinical aspects of hunger disease in adults. In: Winick M (ed) Hunger Disease: Studies by the Jewish Physicians in the Warsaw Ghetto. New York, NY: John Wiley and Sons, 1979; 11-43.
9. Cozzaglio L, Balzola F, Cosentino F et al. Outcome of cancer patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 1997; 21: 339-342.
10. Pironi L, Ruggeri E, Tanneberger S et al. Home artificial nutrition in advanced cancer. J R Soc Med 1997; 90: 597-603.
11. Pasanisi F, Orban A, Scalfi L et al. Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 2001; 17: 581-584.
12. Santarpia L, Alfonsi L, Pasanisi F et al. Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition 2006; 22: 355-360.
13. Chermesh I, Mashiach T, Amit A et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks? Med Oncol 2011; 28: 83-88.
14. Martin L, Senesse P, Gioulbasanis I et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 2015; 33: 90-99.
15. Mercadante S. Bowel obstruction in home-care cancer patients: 4 years experience. Support Care Cancer 1995; 3: 190-193.
16. Porzio G, Aielli F, Verna L et al. Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer 2011; 19: 431-433.
17. Culine S, Chambrier C, Tadmouri A et al. Home parenteral nutrition improves quality of life and nutritional status in patients with cancer: a French observational multicentre study. Support Care Cancer 2014; 22: 1867-1874.
18. Senesse P, Tadmouri A, Culine S et al. A prospective observational study assessing home parenteral nutrition in patients with gastrointestinal cancer: benefits for quality of life. J Pain Symptom Manage 2015; 49: 183-191.e2.
19. Vashi PG, Dahlk S, Popiel B et al. A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer 2014; 14: 593.
20. Bozzetti F, Cozzaglio L, Biganzoli E et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 2002; 21: 281-288.
21. Bozzetti F, Zupec-Kania B. Toward a cancer-specific diet. Clin Nutr 2015 Jan 23 [epub ahead of print], doi:10.1016/j.clnu.2015.01.013.
22. Bozzetti F, Bozzetti V. Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature. Clin Nutr 2013; 32: 142-146.